Source link : https://www.newshealth.biz/health-news/early-success-seen-with-car-t-cell-therapy-for-ssc/
TOPLINE: CD19-targeting chimeric antigen receptor (CAR) T-cell therapy shows potential to intercept fibrotic organ manifestations and improve disease measures in patients with diffuse cutaneous systemic sclerosis (SSc) who had disease progression despite multiple previous treatments. METHODOLOGY: Researchers conducted a case series to examine the effect of CD19-targeting CAR T-cell therapy on fibrotic and vascular organ […]
Author : News Health
Publish date : 2024-12-13 11:38:52
Copyright for syndicated content belongs to the linked Source.